Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sample size graphs for "proving the null hypothesis".

W C Blackwelder, M A Chang

    Controlled Clinical Trials
    |June 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Etramp5 as a useful serological marker in children to assess the immediate effects of mass drug campaigns for malaria.

    BMC infectious diseases·2022
    Same author

    IL-1β induces p62/SQSTM1 and represses androgen receptor expression in prostate cancer cells.

    Journal of cellular biochemistry·2014
    Same author

    A comparison of the potential acuity meter (PAM) and the illuminated near card (INC) in patients undergoing phacoemulsification.

    Eye (London, England)·2005
    Same author

    Current issues in clinical equivalence trials.

    Journal of dental research·2004
    Same author

    Occupational risk for nephrolithiasis and bladder dysfunction in a chauffeur.

    Urological research·2003
    Same author

    Allocation of subjects to test null relative risks smaller than one.

    Statistics in medicine·2001
    Same journal

    On the generation and ownership of alpha in medical studies.

    Controlled clinical trials·2004
    Same journal

    An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

    Controlled clinical trials·2004
    Same journal

    Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

    Controlled clinical trials·2004
    Same journal

    Statistical comparison of random allocation methods in cancer clinical trials.

    Controlled clinical trials·2004
    Same journal

    Analyzing bronchodilation with emphasis on disease type, age and sex.

    Controlled clinical trials·2004
    Same journal

    Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

    Controlled clinical trials·2004
    See all related articles

    This study provides sample size graphs for clinical trials comparing experimental and standard therapies. These graphs help determine the necessary sample size to detect a specified difference in success probabilities.

    Area of Science:

    • Clinical trials methodology
    • Biostatistics
    • Pharmaceutical research

    Background:

    • Determining appropriate sample size is crucial for the validity and efficiency of clinical trials.
    • Comparing the efficacy of experimental therapies against established standard therapies requires robust statistical planning.
    • Previous methods for sample size calculation may not cover all desired parameters for comparative effectiveness studies.

    Purpose of the Study:

    • To present graphical tools for determining sample size in clinical trials.
    • To facilitate the design of trials comparing an experimental therapy to a standard therapy.
    • To provide sample size estimations for various significance levels, error probabilities, and minimum detectable differences.

    Main Methods:

    • Utilized statistical formulas for sample size calculation based on a dichotomous outcome.

    Related Experiment Videos

  • Assumed a one-sided hypothesis test for therapy effectiveness.
  • Generated graphs illustrating sample size requirements across a range of significance levels (alpha), Type II error rates (beta), and minimum success probability differences (delta).

    • Main Results:

    • Provided comprehensive sample size graphs for common clinical trial parameters.
    • Graphs cover alpha levels of 0.01, 0.025, and 0.05.
    • Included beta error rates of 0.10 and 0.20, and delta values of 0.10 and 0.20.

    Conclusions:

    • The presented graphs serve as a practical resource for researchers designing comparative clinical trials.
    • These tools aid in ensuring adequate statistical power to detect meaningful differences in therapy effectiveness.
    • Efficient trial design is supported by the ability to visualize sample size needs based on key statistical parameters.